PAK4 in Melanoma: Could This Target Extend Immunotherapy’s Reach?
Combining PD-1 blockade with PAK4 inhibitors could boost the number of patients helped by the therapy.
Skin Cancer/Precancer
SKIN CANCER/PRECANCER
FEATURE ARTICLE
LATEST NEWS
Circulating Tumor Cells Predict Relapse in Stage III Melanoma
For stage III melanoma patients, circulating tumor cells predict relapse.
Therapeutic Advancements Have Facilitated Surgery Optimization, ASCO Officials Report
ASCO outlined advances in oncology that were the most clinically meaningful or had the biggest scientific impact from October 2018 through September 2019.
Risk Factors Associated With Central Nervous System Metastasis in Stage III Melanoma
Researchers aimed to identify clinicopathologic characteristics of patients with stage III melanoma who would benefit from regular CNS imaging.
Industry Ties May Bias Indoor Tanning Studies
Although they comprise a small percentage of all published articles, articles with financial links to the indoor tanning industry are more likely to favor indoor tanning.
Self-Examination Identifies Majority of Lesions After Melanoma Treatment
The need for skin examinations for patients with metastatic melanoma is evaluated in this novel study, which noted that a greater number of subsequent skin lesions were found by the patient.
Nail Apparatus Melanoma Features Good Survival and Functional Outcome
Treatment and outcomes of nail apparatus melanoma are outlined in this study that finds a high survival rate—and that conservative treatment yields high patient satisfaction.
Satisfaction High With Mohs Surgery for Melanoma In Situ
Patients are very satisfied with Mohs micrographic surgery (MMS) for melanoma in situ.
Lack of Self-Exams Hampers Early Melanoma Identification
The biggest obstacle to early detection and treatment of melanoma among residents of rural, frontier communities is a chronic lack of skin self-examination.
Ablative Fractional Laser, Ingenol Mebutate Gel Show Promising Treatment Efficacy for Low-Risk BCCs
Two treatments of combined AFL and IM show potential to treat low-risk BCCs with acceptable tolerability. OCT and RCM show promise to detect subclinical BCCs at short-term follow up.
2012 to 2014 Saw Increase in US Patients With Skin Malignancy
From 2012 to 2014, 41,185 patients with a diagnosis of skin malignancy of the head and neck region were identified, mostly with a diagnosis of nonmelanoma skin cancer.
Want to read more?
Please login or register first to view this content.